For these reasons, the present study focused on CTGF-mediated MAPK and TGF-β/SMAD signaling to elucidate the possible mechanisms of cucurbitacin I-mediated inhibition of cardiac hypertrophy. This evidence concerns the gene CCN2 and cardiac hypertrophy.